Quick Overview: Hans Lee, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, explores strategies to Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, shares some ... Niels van de Donk, MD, PhD, of VU University Medical Center, Amsterdam, Netherlands, gives an overview of the use of B-cell ...

Improving Outcomes Of Bcma Targeting - Detailed Overview & Context

Hans Lee, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, explores strategies to Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, shares some ... Niels van de Donk, MD, PhD, of VU University Medical Center, Amsterdam, Netherlands, gives an overview of the use of B-cell ... In this video, Hans Lee, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of Andrew Yee, MD, Massachusetts General Hospital Cancer Center, Boston, MA, highlights the transformative impact of ... Nikhil Munshi, MD, MBBS, Dana-Farber Cancer Institute, Boston, MA, outlines the use of the B-cell maturation antigen (

Hans Lee, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the important role of Sagar Lonial, Winship Cancer Institute of Emory University, Atlanta, GA, discusses the promising Jack Khouri, MD, Cleveland Clinic, Cleveland, OH, comments on a study investigating the Shebli Atrash, MD, Levine Cancer Institute, Charlotte, NC, discusses the Niels van de Donk, MD, PhD, of VU University Medical Center, Amsterdam, Netherlands, talks on the sequencing of B-cell ... In this video, Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, ...

Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Stephan Grupp, MD, PhD, ... Aytaj Mammadzadeh, MD, US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS, discusses a ... In this video, Hans Lee, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the importance of GPRC5D ... Carlos Fernandez de Larrea, MD, PhD, University of Barcelona, Barcelona, Spain, discusses the challenges associated with ... Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, of the University College London Hospitals, London, UK, highlights B-cell ...

Photo Gallery

Improving outcomes of BCMA-targeting ADCs in multiple myeloma
The value of BCMA-targeting therapy in multiple myeloma: current applications and future outlooks
BCMA-targeted BiTEs for multiple myeloma
Using BCMA-targeting agents in earlier lines of treatment for multiple myeloma
The transformative impact of BCMA-targeting bispecific antibodies in RRMM
BCMA-Targeted Therapies in Multiple Myeloma
BCMA targeting agents in myeloma
The importance of BCMA-targeting ADCs and bispecific antibodies in R/R multiple myeloma
Sequencing BCMA‐ and GPRC5D‐targeting immunotherapies in multiple myeloma
BCMA-targeting CAR-T: lessons moving forward
Outcomes of teclistamab in RRMM with prior exposure to BCMA-directed therapy
The value of BCMA-targeting agents in treating patients with penta-refractory multiple myeloma
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored